Australian-based AFT Pharmaceuticals has extended the global distribution of painkiller Maxigesic to now include over 120 countries.
-
Latest News AFT secures new deal for Maxigesic July 21, 2017
-
Latest News New HCV therapy for PBS in August July 20, 2017Gilead's EPLCUSA (sofosbuvir with velpatasvir) will be listed for the treatment of adults with all types of chronic hepatitis C infection (HCV).
-
Latest News First generics of popular pain therapy July 20, 2017A raft of generics will be listed on the PBS on 1 August, triggering a statutory price reduction, price disclosure and fierce competition at pharmacy-level for a share of what is currently a $170 million product.
-
Latest News Government will be rebating the rebates but not with interest? July 19, 2017It represents a profound change in how rebates will be administered, calculated and paid.
-
TGA approves another immunotherapy July 19, 2017Another immunotherapy is making progress towards reimbursement following TGA approval of Janssen's DARZALEX (daratumumab) for the treatment of multiple myeloma.
-
Latest News Growing concern over the administration of 'deeds' July 18, 2017The recent revelation government was moving to change the budgeting of rebates has unleashed a raft of complaints from companies about the administration of 'deeds'.
-
Latest News Tension rising after submission cap July 17, 2017Medicines Australia and the Department of Health are at odds over a decision to exclude some major submissions from the November PBAC meeting.
-
PharmaDispatch Executive 'We can't afford not to be part of the discussion' July 17, 2017According to departing AstraZeneca boss Paul Spittle, “The challenge going forward for Australian policy-makers, and industry, is to consider how close we are to ‘hitting a brick wall’ on access to new medicines."
-
Latest News Affordability of medicines an issue for Australian patients July 17, 2017A new report from US-based think-tank The Commonwealth Fund ranks Australia as having the second best health system in a comparison of 11 developed countries.
-
Latest News Industry PBAC nomination finally revealed July 13, 2017The former Bristol-Myers Squibb senior market access executive is the industry nominated PBAC member.
-
DUSC outcomes on Crohn's and migraine July 13, 2017The outcomes statement from DUSC's June meeting shows it found higher than anticipated utilisation of some key medicines.
New Stories
-
Another senior official leaves pharmaceutical benefits
July 21, 2017 - -
TPP11 discussions continue
July 21, 2017 - Latest News -
Second year of Astellas C3 Prize
July 21, 2017 - Latest News -
AFT secures new deal for Maxigesic
July 21, 2017 - Latest News -
New HCV therapy for PBS in August
July 20, 2017 - Latest News -
First generics of popular pain therapy
July 20, 2017 - Latest News -
Quilty: Whole of sector challenge
July 20, 2017 - Latest News